Tirzepatide + 5-Amino-1MQ + NAD+ nasal spray: does the fat-loss stack match the science?

A TikTok clip from @genxnp76 promotes a 'fat burning peptide' stack combining tirzepatide, 5-Amino-1MQ, and NAD+ nasal spray, claiming appetite control, fat burn, and energy 'without sacrificing muscle or sanity.' The video frames this as metabolic optimization, but how much of this is backed by peer-reviewed evidence?

What the clip claims

The creator presents the stack as a comprehensive solution for fat loss: tirzepatide for appetite and glucose control, 5-Amino-1MQ for fat oxidation, and NAD+ for cellular energy. The implication is that these three compounds work synergistically to enhance metabolic rate while preserving lean mass.

What research actually covers

Tirzepatide is a GLP-1/GIP receptor agonist approved for type 2 diabetes and obesity. Clinical trials show significant weight loss, primarily via reduced caloric intake and improved insulin sensitivity. Its effects on muscle preservation are less clear; some studies suggest a proportion of weight lost is lean mass, though resistance training may mitigate this.

5-Amino-1MQ is a small molecule that inhibits NNMT (nicotinamide N-methyltransferase), an enzyme linked to fat metabolism. Preclinical studies in mice show increased fat oxidation and reduced adiposity, but human data are absent. No published trials confirm its efficacy or safety in people.

NAD+ precursors (like nicotinamide riboside or NMN) are studied for cellular energy and aging, but NAD+ itself in nasal spray form has limited bioavailability evidence. Intranasal delivery may bypass some barriers, but clinical proof of meaningful metabolic benefits is lacking.

Limits of the evidence

No clinical trial has tested this exact triple combination. Interactions between tirzepatide and 5-Amino-1MQ are unexplored. NAD+ nasal sprays are not standardized, and their systemic effects are variable. The 'without sacrificing muscle' claim is not supported by direct evidence for this stack.

Research-use caveat

All compounds mentioned are for research use only (RUO) in many jurisdictions. They are not approved for over-the-counter weight loss. Any use in humans outside approved indications is experimental and carries unknown risks. Always consult a qualified healthcare provider for medical advice.

Open the full video fact-check page (transcript, takeaways, embedded clip).